Immunotherapy drug boosts lung cancer survival – study

Immunotherapy drug boosts lung cancer survival – study

Lung cancer patients taking a game-changing drug are five times more likely to be alive after five years than those on chemotherapy, research suggests.

The immunotherapy drug nivolumab (Opdivo), which is used for several cancers, works by blocking a protein that stops the immune system attacking cancer cells.

The drug helps the patient’s own immune system find and destroy cancer cells as they spread.

Now, new research presented at the World Conference on Lung Cancer in Barcelona shows the drug can have a powerful effect in extending survival for people with advanced lung cancer who have few treatment options.

Research on 854 patients, presented by Dr Scott Gettinger of Yale Comprehensive Cancer Centre in the US, showed that those on the drug were five times more likely to still be alive after five years than those on conventional chemotherapy (docetaxel).

Five-year survival rates were 13.4% for people on the drug compared to 2.6% for those on chemotherapy.

The overall survival benefit with nivolumab compared with docetaxel was observed across sub groups of patients, including those who were previously thought to derive lesser benefit from the drug.

It is the first time clinical data has been presented showing how patients are faring after five years on the medicine.

- Press Association

More on this topic

Tipperary firm ups the fight against cancerTipperary firm ups the fight against cancer

Poem on a pill highlights cancer fightPoem on a pill highlights cancer fight

Friends plead for financial support for funeral of cancer awareness advocate Tina PottsFriends plead for financial support for funeral of cancer awareness advocate Tina Potts

Cervical cancer patients under stress ‘face higher risk of death’: Swedish studyCervical cancer patients under stress ‘face higher risk of death’: Swedish study

More in this Section

How can the UK Government deliver Brexit on October 31 and comply with the law?How can the UK Government deliver Brexit on October 31 and comply with the law?

Iran arms likely used in oil attack – Saudi militaryIran arms likely used in oil attack – Saudi military

'Deeply sorry': Cameron ‘haunted’ by EU referendum decision'Deeply sorry': Cameron ‘haunted’ by EU referendum decision

'Your people, our people, count on you': EU steps up demands for Boris Johnson to come up with Brexit proposals'Your people, our people, count on you': EU steps up demands for Boris Johnson to come up with Brexit proposals


Lifestyle

Make-up artist Terry Barber reveals the secret to pulling off the bold lip look.This is how to make black lipstick work in real life, according to a catwalk make-up pro

Off to the Japan? After a trip to Tokyo, Ella Walker outlines the best things to eat between matches.These are the dishes to try if you’re going to Tokyo for the Rugby World Cup

It still surprises me as I am achingly private and do not enjoy being at the centre of attention.This Much I Know: Actor Aislin McGuckin

Bride Geraldine O’Donovan felt as wonderful as she looked on her big day — knowing she was supporting a cause close to her heart as she donned her wedding gown.Wedding on the Week: Supporting a cause close to their hearts

More From The Irish Examiner